- Home
- ASIX vs LAB Comparison
ASIX vs LAB Comparison
Compare ASIX & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASIX | LAB |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.1M | 449.9M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | ASIX | LAB |
|---|---|---|
| Price | $16.08 | $1.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $32.00 | $1.35 |
| AVG Volume (30 Days) | 493.9K | ★ 2.0M |
| Earning Date | 11-07-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.93% | N/A |
| EPS Growth | ★ 35.47 | N/A |
| EPS | ★ 1.92 | N/A |
| Revenue | ★ $1,491,348,000.00 | $169,737,000.00 |
| Revenue This Year | $4.71 | N/A |
| Revenue Next Year | $4.59 | N/A |
| P/E Ratio | $8.49 | ★ N/A |
| Revenue Growth | N/A | ★ 79.77 |
| 52 Week Low | $14.10 | $0.92 |
| 52 Week High | $32.58 | $2.25 |
Technical Indicators
Market Signals| Indicator | ASIX | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 48.26 | 63.46 |
| Support Level | $15.20 | $1.44 |
| Resistance Level | $17.29 | $1.51 |
| Average True Range (ATR) | 0.60 | 0.07 |
| MACD | 0.23 | 0.00 |
| Stochastic Oscillator | 45.76 | 61.76 |
Price Performance
Historical ComparisonAbout ASIX AdvanSix Inc.
AdvanSix Inc. is a diversified chemistry company playing a critical role in globally supply chains, innovating and delivering essential products for customers in a wide variety of end markets and applications that touch people's lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. The company key products includes: Nylon, Caprolactam, Plant Nutrients, and Chemical Intermediates The majority of sales is from Plant Nutrients products.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.